Figure 2. Onset of symptoms and percent survival of mice infected with CVS 10^-6.22 (approximately 1.35LD₅₀) and treated with bufotenine 0.63 mg/animal/day. (a) Rabies control group: symptoms onset on mice infected with CVS 10^-6.82; (b) treatment group: symptoms onset on mice infected with CVS 10^-6.82 and treated with bufotenine 0.63 mg/animal/day; (c) percentage survival of control group, rabies control group and treatment group. p value summary: * p ≤ 0.05 in Log-rank (Mantel-Cox) Test, ** p ≤ 0.01 in Gehan-Breslow-Wilcoxon Test.